Bio Active Protein and Peptides are peptide compounds that have beneficial or physiological effects on the life activities of living organisms. They are a class of peptides with a relative molecular mass of less than 6000 Da and various biological functions. Bioactive peptides have a variety of human metabolism and physiological regulation functions, easy to digest and absorb, and have the functions of promoting immunity, hormone regulation, antibacterial, antiviral, lowering blood pressure, lowering blood fat, etc.
Highlights
The global Bio Active Protein and Peptides market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Increasing health concerns and growing awareness of nutraceutical products among consumers are the primary factors expected to drive the global bio active protein and peptides market in the near future. Bio active protein and peptides display a number of physiological functionalities such as improving cardiovascular, nervous, gastrointestinal, and immune systems. A growing aging population and increasing incidence of chronic diseases among the people globally are other factors anticipated to drive revenue growth of the global bio active protein and peptides market. Also, a growing preference for bio active protein and peptides in cosmetics and personal care is likely to boost the global bio active protein and peptides market over the forecast period. However, stringent rules and regulations leading to increased operational costs and supply chain issues create a barrier for manufacturers operating in the global bio active protein and peptides market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio Active Protein and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Active Protein and Peptides.
The Bio Active Protein and Peptides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bio Active Protein and Peptides market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Active Protein and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Archer Daniels Midland Company
Kerry Group
Cargill
Omega Protein Corporation
Bunge
DuPont
Fonterra Co-operative Group
Royal DSM
Segment by Type
Plant Source
Animal Source
Segment by Application
Functional Food
Functional Beverages
Dietary Supplements
Animal Nutrition
Personal Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio Active Protein and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bio Active Protein and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Bio Active Protein and Peptides 麻豆原创 Overview
1.1 Product Overview and Scope of Bio Active Protein and Peptides
1.2 Bio Active Protein and Peptides Segment by Type
1.2.1 Global Bio Active Protein and Peptides 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Bio Active Protein and Peptides Segment by Application
1.3.1 Global Bio Active Protein and Peptides 麻豆原创 Value by Application: (2023-2029)
1.3.2 Functional Food
1.3.3 Functional Beverages
1.3.4 Dietary Supplements
1.3.5 Animal Nutrition
1.3.6 Personal Care
1.3.7 Others
1.4 Global Bio Active Protein and Peptides 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Bio Active Protein and Peptides Revenue 2018-2029
1.4.2 Global Bio Active Protein and Peptides Sales 2018-2029
1.4.3 Global Bio Active Protein and Peptides 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bio Active Protein and Peptides 麻豆原创 Competition by Manufacturers
2.1 Global Bio Active Protein and Peptides Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Bio Active Protein and Peptides Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Bio Active Protein and Peptides Average Price by Manufacturers (2018-2023)
2.4 Global Bio Active Protein and Peptides Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bio Active Protein and Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bio Active Protein and Peptides, Product Type & Application
2.7 Bio Active Protein and Peptides 麻豆原创 Competitive Situation and Trends
2.7.1 Bio Active Protein and Peptides 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bio Active Protein and Peptides Players 麻豆原创 Share by Revenue
2.7.3 Global Bio Active Protein and Peptides 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bio Active Protein and Peptides Retrospective 麻豆原创 Scenario by Region
3.1 Global Bio Active Protein and Peptides 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bio Active Protein and Peptides Global Bio Active Protein and Peptides Sales by Region: 2018-2029
3.2.1 Global Bio Active Protein and Peptides Sales by Region: 2018-2023
3.2.2 Global Bio Active Protein and Peptides Sales by Region: 2024-2029
3.3 Global Bio Active Protein and Peptides Global Bio Active Protein and Peptides Revenue by Region: 2018-2029
3.3.1 Global Bio Active Protein and Peptides Revenue by Region: 2018-2023
3.3.2 Global Bio Active Protein and Peptides Revenue by Region: 2024-2029
3.4 North America Bio Active Protein and Peptides 麻豆原创 Facts & Figures by Country
3.4.1 North America Bio Active Protein and Peptides 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bio Active Protein and Peptides Sales by Country (2018-2029)
3.4.3 North America Bio Active Protein and Peptides Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bio Active Protein and Peptides 麻豆原创 Facts & Figures by Country
3.5.1 Europe Bio Active Protein and Peptides 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bio Active Protein and Peptides Sales by Country (2018-2029)
3.5.3 Europe Bio Active Protein and Peptides Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bio Active Protein and Peptides 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Bio Active Protein and Peptides 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bio Active Protein and Peptides Sales by Country (2018-2029)
3.6.3 Asia Pacific Bio Active Protein and Peptides Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bio Active Protein and Peptides 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Bio Active Protein and Peptides 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bio Active Protein and Peptides Sales by Country (2018-2029)
3.7.3 Latin America Bio Active Protein and Peptides Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bio Active Protein and Peptides 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Bio Active Protein and Peptides 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bio Active Protein and Peptides Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bio Active Protein and Peptides Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bio Active Protein and Peptides Sales by Type (2018-2029)
4.1.1 Global Bio Active Protein and Peptides Sales by Type (2018-2023)
4.1.2 Global Bio Active Protein and Peptides Sales by Type (2024-2029)
4.1.3 Global Bio Active Protein and Peptides Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Bio Active Protein and Peptides Revenue by Type (2018-2029)
4.2.1 Global Bio Active Protein and Peptides Revenue by Type (2018-2023)
4.2.2 Global Bio Active Protein and Peptides Revenue by Type (2024-2029)
4.2.3 Global Bio Active Protein and Peptides Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Bio Active Protein and Peptides Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bio Active Protein and Peptides Sales by Application (2018-2029)
5.1.1 Global Bio Active Protein and Peptides Sales by Application (2018-2023)
5.1.2 Global Bio Active Protein and Peptides Sales by Application (2024-2029)
5.1.3 Global Bio Active Protein and Peptides Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Bio Active Protein and Peptides Revenue by Application (2018-2029)
5.2.1 Global Bio Active Protein and Peptides Revenue by Application (2018-2023)
5.2.2 Global Bio Active Protein and Peptides Revenue by Application (2024-2029)
5.2.3 Global Bio Active Protein and Peptides Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Bio Active Protein and Peptides Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Archer Daniels Midland Company
6.1.1 Archer Daniels Midland Company Corporation Information
6.1.2 Archer Daniels Midland Company Description and Business Overview
6.1.3 Archer Daniels Midland Company Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Product Portfolio
6.1.5 Archer Daniels Midland Company Recent Developments/Updates
6.2 Kerry Group
6.2.1 Kerry Group Corporation Information
6.2.2 Kerry Group Description and Business Overview
6.2.3 Kerry Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kerry Group Bio Active Protein and Peptides Product Portfolio
6.2.5 Kerry Group Recent Developments/Updates
6.3 Cargill
6.3.1 Cargill Corporation Information
6.3.2 Cargill Description and Business Overview
6.3.3 Cargill Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cargill Bio Active Protein and Peptides Product Portfolio
6.3.5 Cargill Recent Developments/Updates
6.4 Omega Protein Corporation
6.4.1 Omega Protein Corporation Corporation Information
6.4.2 Omega Protein Corporation Description and Business Overview
6.4.3 Omega Protein Corporation Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Omega Protein Corporation Bio Active Protein and Peptides Product Portfolio
6.4.5 Omega Protein Corporation Recent Developments/Updates
6.5 Bunge
6.5.1 Bunge Corporation Information
6.5.2 Bunge Description and Business Overview
6.5.3 Bunge Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bunge Bio Active Protein and Peptides Product Portfolio
6.5.5 Bunge Recent Developments/Updates
6.6 DuPont
6.6.1 DuPont Corporation Information
6.6.2 DuPont Description and Business Overview
6.6.3 DuPont Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.6.4 DuPont Bio Active Protein and Peptides Product Portfolio
6.6.5 DuPont Recent Developments/Updates
6.7 Fonterra Co-operative Group
6.6.1 Fonterra Co-operative Group Corporation Information
6.6.2 Fonterra Co-operative Group Description and Business Overview
6.6.3 Fonterra Co-operative Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fonterra Co-operative Group Bio Active Protein and Peptides Product Portfolio
6.7.5 Fonterra Co-operative Group Recent Developments/Updates
6.8 Royal DSM
6.8.1 Royal DSM Corporation Information
6.8.2 Royal DSM Description and Business Overview
6.8.3 Royal DSM Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Royal DSM Bio Active Protein and Peptides Product Portfolio
6.8.5 Royal DSM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bio Active Protein and Peptides Industry Chain Analysis
7.2 Bio Active Protein and Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bio Active Protein and Peptides Production Mode & Process
7.4 Bio Active Protein and Peptides Sales and 麻豆原创ing
7.4.1 Bio Active Protein and Peptides Sales Channels
7.4.2 Bio Active Protein and Peptides Distributors
7.5 Bio Active Protein and Peptides Customers
8 Bio Active Protein and Peptides 麻豆原创 Dynamics
8.1 Bio Active Protein and Peptides Industry Trends
8.2 Bio Active Protein and Peptides 麻豆原创 Drivers
8.3 Bio Active Protein and Peptides 麻豆原创 Challenges
8.4 Bio Active Protein and Peptides 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Archer Daniels Midland Company
Kerry Group
Cargill
Omega Protein Corporation
Bunge
DuPont
Fonterra Co-operative Group
Royal DSM
听
听
*If Applicable.